Formoterol Fumarate

富马酸福莫特罗

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NameFormoterol Fumarate
Drug Alias Name福莫特罗延胡索酸盐Eformoterol fumarate富马酸福莫特罗formoterolformoterolum +[22] 
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsCognitive DysfunctionEmphysemaDiabetic Nephropathies +[8] 
Global Approved IndicationsEmphysemaPulmonary Disease, Chronic ObstructiveBronchial Spasm +[5] 
Approved Indications in ChinaEmphysemaAsthmaBronchitis
Original Approved Country/TerritorySweden
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesMundipharma Research LtdDeyPearl Therapeutics Inc +[7] 
Active IndicationsEmphysemaDiabetic NephropathiesPulmonary Disease, Chronic Obstructive +[5] 
Inactive IndicationsCognitive DysfunctionAlzheimer DiseaseBronchial Spasm

Other Information

ATC CodeR03AC13
Related LinksWikipediaDrugBankKEGG